Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita says price of Amgen’s Epogen raised 3.9 pct
Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 Thursday May 10, 6:59 am Eastern Time TORRANCE, Calif., May 10 (Reuters) – DaVita Inc. (NYSE:DVA), an…
-
Amgen Raises EPOGEN Pricing
DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective May 9, 2001 at 5:01 PM Pacific Time. This pricing…
-
DaVita Inc. Reports 1st Quarter 2001 Results
DaVita Inc. , today announced results for the quarter ended March 31, 2001. Net earnings for the first quarter were $21.3 million or $0.24 per share. Continental U.S. EBITDA (earnings before…
-
DaVita Completes $225 Million Private Offering 9 1/4% Senior Subordinated Notes
DaVita Inc. , announced today that it has completed the sale of $225 million of its 9 1/4% Senior Subordinated Notes Due 2001 (the “Notes”) in a private offering. The Notes mature on April 15,…
-
DaVita Inc. Announces Date for Q1 Earnings Release
To: Members of the Investment Community From: LeAnne Zumwalt, Vice President Re: DaVita Inc. Q1 2001 Earnings Release Date: April 6, 2001 We are planning a conference call to discuss our Q1 2001…